During the past decade, Ospedale Dell'Angelo conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 5 clinical trials were completed, i.e. on average, 18.5% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 5 clinical trials were completed. i.e. 38.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedale Dell'Angelo" #1 sponsor was "Abbott Medical Devices" with 3 trials, followed by "Boston Scientific Corporation" with 3 trials sponsored, "Fondazione Italiana Linfomi ONLUS" with 2 trials sponsored, "Istituto Oncologico Veneto IRCCS" with 2 trials sponsored and "Mario Negri Institute for Pharmacological Research" with 2 trials sponsored. Other sponsors include 20 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale Dell'Angelo" #1 collaborator was "University of Padova" with 2 trials as a collaborator, "Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia" with 1 trials as a collaborator, "Boston Scientific Corporation" with 1 trials as a collaborator, "Cancer Trials Ireland" with 1 trials as a collaborator and "Dipartimento di scienze chirurgiche, Oncologiche e Gastroenterologiche" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale Dell'Angelo" are "Atrial Fibrillation" (2 trials), "Coronary Artery Disease" (2 trials), "Multiple Myeloma" (2 trials), "Stem Cell Transplant Complications" (2 trials) and "Acute Myelogenous Leukemia" (1 trials). Many other conditions were trialed in "Ospedale Dell'Angelo" in a lesser frequency.

Most popular intervention types in "Ospedale Dell'Angelo" are "Drug" (16 trials), "Device" (10 trials), "Other" (5 trials), "Procedure" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Deep Brain Stimulation (DBS)" (2 trials), "Dexamethasone" (2 trials), "Angio" (1 trials), "Aromatase Inhibitors" (1 trials) and "Atezolizumab 1200 mg in 20 ML Injection" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale Dell'Angelo" are 35 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Ospedale Dell'Angelo". undefined are not yet recruiting, 12 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Ospedale Dell'Angelo, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale Dell'Angelo, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 6 trials that are defined as “Not Applicable".